Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
2022 · Infectious Diseases and Therapy · 37 citations
https://doi.org/10.1007/s40121-022-00703-y